Posted inBiotechnology
3′-Sialyllactose curbs atherosclerosis via gut-immune-cardiovascular axis in mice
A sugar found in human breast milk may hold the key to preventing one of the world’s leading causes of…
Posted inBiotechnology
Open-source tool automates volcanic cone analysis on Mars and Earth
Scientists measuring volcanic cones on Mars and Earth have long faced a frustrating bottleneck: the landscape is full of cones,…
Posted inBiotechnology
Defending federated learning from backdoors with semantic filters and geometry
Federated learning has become one of the most consequential architectures in modern machine learning, allowing thousands of devices to collectively…
Posted inBiotechnology
New Fusion-Based Method Detects Drones at Long Range in Cluttered Backgrounds
Detecting a small drone at the far edge of a camera’s field of view has long been one of the…
Posted inBiotechnology
Real-time multimedia CPR training feedback using pose estimation and action recognition
A team of researchers in Taiwan has built an artificial intelligence system that watches people perform cardiopulmonary resuscitation and tells…
Posted inBiotechnology
Researchers build GPU-based distributed computing framework
As data centers around the world grapple with workloads that double in scale year after year, a team of researchers…
Posted inBiotechnology
AI Disclosure and Emotional Support in Chatbot Talks with International Students
In an era when millions of young people turn to conversational artificial intelligence for comfort during moments of loneliness, sadness,…
Posted inBiotechnology
Magnetic regulation robot design tackles obstacle-crossing challenges
Robots that crawl along steel walls to inspect ships, storage tanks, bridges, and pipelines have long faced a stubborn trade-off:…
Posted inBiotechnology
KSVoteRank: identifying dispersed key nodes through k-shell and voting methods
In the vast web of connections that makes up social networks, transportation systems, communication infrastructure, and even the human brain,…
Posted inBiotechnology
Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial
Novartis’ Ionis-partnered drug designed to lower levels of Lp(a), a known cardiovascular risk factor, failed to reduce patients’ risk of…